Alembic Pharmaceuticals receives USFDA Tentative Approval for Olopatadine Hydrochloride Ophthalmic Solution USP 0.7 % (OTC) ...

The Prosthetic Replacement of Ocular Surface Ecosystem was well-tolerated and appeared efficacious as a delivery system for ...

Ophthalmic nonsteroidal anti-inflammatory agents may increase the risk of bleeding in ocular tissues following ophthalmic procedures (prescribing information, Volaten Ophthalmic, CIBA Vision ...

and Opti-Free Express MultiPurpose Disinfecting Solution (Alcon), as well as other storage solutions for contact lenses. SofZia™ is the most recent advancement in the field of ophthalmic ...

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 pivotal trial, according to a press release from Tenpoint Therapeutics.

Please find attached herewith the Final Approval received for Diltiazem Hydrochloride Extended - Release capsule USP 120 mg, 180 mg and 240 mg.